OnKure Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 4, 2026, OnKure Therapeutics, Inc. announced and furnished a press release reporting its financial results for the quarter ended June 30, 2026. The press release is attached to the Form 8-K as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: August 4, 2026 (Form 8-K).
• Reporting period: quarter ended June 30, 2026 (quarterly results / earnings disclosed in the attached press release).
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.
• Legal note: The information furnished (including Exhibit 99.1) is expressly not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically stated.

Why It Matters

• This 8-K signals OnKure released its latest quarterly results (earnings, revenue, and other financial metrics) — investors should review the attached press release for concrete figures and operational updates.
• Because the release is furnished rather than “filed,” it has different legal treatment under the securities laws; investors should rely on the press release for current reported metrics and consult other SEC filings for information incorporated by reference.